Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.8 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.8 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |